RxDoctor Payments Data

Syeda Kazmi, DPM

Podiatrist · College Station, TXNPI 1538788534

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $1,513 of the $2,434 with a category attached, or 62.2%. Paragon 28, Inc. accounts for 67.1% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2023 at $1,806 and has fallen 96.0% since, to $72 in 2025. That places this record below the midpoint for podiatrist clinicians in TX, where the typical reported total is $1,991.

$2,434in general payments, 2019–2025

Across 37 payments — averaging $65.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Paragon 28, Inc.$2K
  • Treace Medical Concepts, Inc.$374
  • AbbVie$191
  • Paratek Pharmaceuticals, Inc.$141
  • Convatec Inc.$37
  • Smith+Nephew$30
  • plus $28 from 1 others

What the payments were for

  • Travel & lodging$1,51362%
  • Food & beverage$92138%

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,434 in reported general payments places this provider in the 50th percentile of 470 podiatrist providers in Texas.

See all podiatrist providers in Texas →

Medicare billing

Part B allowed, 2024
$91,713
Medicare patients
294
Services billed
1,330

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciclopirox27$722
Cephalexin108$528
Mupirocin59$383
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip16$343
Methylprednisolone46$230
Gabapentin20$152

Paid to pharmacies, not to this prescriber.

Other podiatrist in College Station

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →